Home / Investor / Successful Use of Investigational Antibiotic, Zaynich (Zidebactam/Cefepime-WCK 5222) to Treat a Cancer Patient in US with Chronic Bilateral Thigh Infection Caused by an Extreme-Drug Resistant Pseudomonas
Successful Use of Investigational Antibiotic, Zaynich (Zidebactam/Cefepime-WCK 5222) to Treat a Cancer Patient in US with Chronic Bilateral Thigh Infection Caused by an Extreme-Drug Resistant Pseudomonas